-
Something wrong with this record ?
Current concept of transurethral resection of bladder cancer: from re-transurethral resection of bladder cancer to en-bloc resection
J. Schraml, JDC. Silva, M. Babjuk,
Language English Country United States
Document type Journal Article, Review
- MeSH
- Cystectomy methods standards trends MeSH
- Neoplasm Invasiveness pathology MeSH
- Humans MeSH
- Neoplasm Recurrence, Local prevention & control MeSH
- Urinary Bladder diagnostic imaging pathology surgery MeSH
- Urinary Bladder Neoplasms diagnostic imaging pathology surgery MeSH
- Disease Progression MeSH
- Reoperation methods standards trends MeSH
- Practice Guidelines as Topic MeSH
- Narrow Band Imaging methods trends MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
PURPOSE OF REVIEW: Transurethral resection of bladder cancer (TURB) is the critical step in the management of nonmuscle invasive bladder cancer (NMIBC). This review presents new improvements in the strategy and technique of TURB as well as in technological developments used for tumour visualization and removal. RECENT FINDINGS: The goal of TURB is to perform complete resection of NMIBC. Tumor visualization during procedure can be improved by enhanced optical technologies. Fluorescence-guided photodynamic diagnosis (PDD) and narrow-band imaging (NBI) used during TURB can improve tumour detection and potentially reduce recurrence rate, their influence on progression, however, remains controversial. TURB can be performed using monopolar or bipolar electrocautery without significant differences in results or safety. To overcome limitations of traditional TURB, the technique of en-bloc resection was introduced to improve the quality of tumour removal. In selected cases, an early re-resection (re-TURB) within 2-6 weeks after initial procedure is recommended. SUMMARY: TURB is a fundamental step in diagnosis and treatment of NMIBC. Urologists should be aware of promising innovations including new imaging and surgical techniques and their potential benefits. Hopefully, new technologies and performance of TURB bring improved outcomes, which can alter the indication criteria for re-TURB.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19035076
- 003
- CZ-PrNML
- 005
- 20191014092409.0
- 007
- ta
- 008
- 191007s2018 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1097/MOU.0000000000000542 $2 doi
- 035 __
- $a (PubMed)30102624
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Schraml, Jan $u Department of Urology, Masaryk Hospital, Ústí nad Labem. Department of Urology, Hospital Motol and 2nd Faculty of Medicine, Charles University, Praha, Czech Republic.
- 245 10
- $a Current concept of transurethral resection of bladder cancer: from re-transurethral resection of bladder cancer to en-bloc resection / $c J. Schraml, JDC. Silva, M. Babjuk,
- 520 9_
- $a PURPOSE OF REVIEW: Transurethral resection of bladder cancer (TURB) is the critical step in the management of nonmuscle invasive bladder cancer (NMIBC). This review presents new improvements in the strategy and technique of TURB as well as in technological developments used for tumour visualization and removal. RECENT FINDINGS: The goal of TURB is to perform complete resection of NMIBC. Tumor visualization during procedure can be improved by enhanced optical technologies. Fluorescence-guided photodynamic diagnosis (PDD) and narrow-band imaging (NBI) used during TURB can improve tumour detection and potentially reduce recurrence rate, their influence on progression, however, remains controversial. TURB can be performed using monopolar or bipolar electrocautery without significant differences in results or safety. To overcome limitations of traditional TURB, the technique of en-bloc resection was introduced to improve the quality of tumour removal. In selected cases, an early re-resection (re-TURB) within 2-6 weeks after initial procedure is recommended. SUMMARY: TURB is a fundamental step in diagnosis and treatment of NMIBC. Urologists should be aware of promising innovations including new imaging and surgical techniques and their potential benefits. Hopefully, new technologies and performance of TURB bring improved outcomes, which can alter the indication criteria for re-TURB.
- 650 _2
- $a cystektomie $x metody $x normy $x trendy $7 D015653
- 650 _2
- $a progrese nemoci $7 D018450
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a úzkopásmové zobrazení $x metody $x trendy $7 D062048
- 650 _2
- $a invazivní růst nádoru $x patologie $7 D009361
- 650 _2
- $a lokální recidiva nádoru $x prevence a kontrola $7 D009364
- 650 _2
- $a směrnice pro lékařskou praxi jako téma $7 D017410
- 650 _2
- $a reoperace $x metody $x normy $x trendy $7 D012086
- 650 _2
- $a močový měchýř $x diagnostické zobrazování $x patologie $x chirurgie $7 D001743
- 650 _2
- $a nádory močového měchýře $x diagnostické zobrazování $x patologie $x chirurgie $7 D001749
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Silva, Joana Do Carmo $u Department of Urology, Hospital Motol and 2nd Faculty of Medicine, Charles University, Praha, Czech Republic.
- 700 1_
- $a Babjuk, Marko $u Department of Urology, Hospital Motol and 2nd Faculty of Medicine, Charles University, Praha, Czech Republic. Department of Urology, Masaryk Hospital, Ústí nad Labem.
- 773 0_
- $w MED00001296 $t Current opinion in urology $x 1473-6586 $g Roč. 28, č. 6 (2018), s. 591-597
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30102624 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20191007 $b ABA008
- 991 __
- $a 20191014092833 $b ABA008
- 999 __
- $a ok $b bmc $g 1451736 $s 1073626
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 28 $c 6 $d 591-597 $e - $i 1473-6586 $m Current opinion in urology $n Curr Opin Urol $x MED00001296
- LZP __
- $a Pubmed-20191007
